C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2004
12/01/2004	EP1481004A2 Streptavidin-binding peptide
12/01/2004	EP1481002A1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/01/2004	EP1481001A2 Prion inhibiting peptides and derivatives thereof
12/01/2004	EP1481000A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004	CN1550232A Use of heterocyclic amide in production of autoimmune diseases inhibitors
12/01/2004	CN1177861C Macrocylic peptides active against the hepatitis V virus
11/2004
11/30/2004	US6825317 Histone deacetylase inhibitor, a major histocompatibility complex class-i molecule expression-promoting agent and anticancer agents
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825206 Treatment of leukemia, solid tumors and brain glioma in mammals using the conjugates
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6824998 For determination in mammals via 1-anthraquinonylhydrazide with p-anialdehyde; drug screening; packaging; kits
11/30/2004	US6824783 Delaying the onset of aids in an hiv- 1 infected individual, comprising administering a peptide which inhibits membrane fusion-associated events, i.e. syncytia formation between hiv-1 infected cells and cells uninfected
11/30/2004	CA2173150C Novel peptide derivatives
11/25/2004	WO2004101762A2 Detection and treatment of cancers of the colon
11/25/2004	WO2004101605A1 Hepatitis c inhibiting compounds
11/25/2004	WO2004101604A2 SYNTHESIS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER USING 3,3-DIMETHYLBUTYRALDEHYDE PRECURSORS
11/25/2004	WO2004101603A1 Statine derivatives for the treatment of alzheimer's disease
11/25/2004	WO2004101602A2 Hepatitis c inhibitor peptide analogs
11/25/2004	WO2004101515A1 A process for the preparation of compounds having an ace inhibitory action
11/25/2004	WO2004101494A1 Calpain inhibitors
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	WO2003103718A3 Intracellular delivery of biological effectors
11/25/2004	WO2003082906A3 Neurotrophic and neuroprotective peptides
11/25/2004	US20040236519 Libraries of confomationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
11/25/2004	US20040236140 Synthesis of N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235754 Dipeptide derivatives
11/25/2004	US20040235735 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040234944 Synthesis and recovery of aspartame involving enzymatic deformylation step
11/25/2004	DE10320781A1 Acylierte Nonadepsipeptide Acylated nonadepsipeptides
11/25/2004	CA2525496A1 Statine derivatives for the treatment of alzheimer's disease
11/24/2004	EP1478666A2 Dermopharmaceutically and cosmetically active oligopeptides
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478652A2 Components for producing amphoteric liposomes
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478405A2 Beta-homolysine conjugates and their use as transport enhancer
11/24/2004	EP1478383A2 Compositions and methods for promoting myocardial and peripheral angiogenesis
11/24/2004	EP1478382A1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
11/24/2004	EP1478328A2 Bioactive keratin peptides
11/24/2004	CN1549826A Compositions and methods of treating diabetes
11/24/2004	CN1548451A Seryl seryl threony aspartic acid
11/24/2004	CN1548450A Glycyl valyl cysteinyl methionine
11/24/2004	CN1548449A Glycyl glycyl aspartyl glutamic acid
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/23/2004	US6822111 Process for production of aspartyl dipeptide ester derivatives
11/23/2004	US6822074 Comprises cyclization of precursor; for improved yield
11/23/2004	US6822073 Immunology diagnosis analyzing; using computer
11/23/2004	US6821783 Transition metal complexes as linkers
11/18/2004	WO2004099784A2 Method for determining a tissue degradation process by detection of fibromodulin neoepitopes
11/18/2004	WO2004099376A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	WO2004099239A1 Acylated lysobactin-type nonadepsipeptides
11/18/2004	WO2004099236A1 A process for the preparation of perindopril using tetramethyluronium salts as coupling reagents
11/18/2004	WO2004099135A2 Hiv prodrugs cleavable by cd26
11/18/2004	WO2004098644A1 Prodrugs cleavable by cd26
11/18/2004	WO2004098628A2 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto
11/18/2004	WO2004098309A1 Hydrolysed casein product comprising tripeptides ipp and/ or vpp
11/18/2004	WO2004087740A3 Preserved and stable compositions containing peptide copper complexes and methods related thereto
11/18/2004	WO2004024755A3 Sarcolysyl derivatives and method for the production thereof
11/18/2004	US20040230073 N-[N-[3-(3-hydroxy-4-methoxyphenyl)-3-methylbutyl]-L- alpha -aspartyl]-L-phenylalanine-1-methyl ester; sweeteners; purity, yield; industrially profitable
11/18/2004	US20040230035 protease/thrombin inhibitors
11/18/2004	US20040230033 Peptides containing electrophilic group having ability to undergo nucleophilic attack with active site cysteine residues in cysteine proteinase enzymes; inhibitors such as staphylococcal surface protein sorting A (SrtA); blot analysis
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	US20040229818 Hepatitis C inhibitor compound
11/18/2004	US20040229811 Compounds and methods for modulating desmosomal cadherin-mediated functions
11/18/2004	US20040229801 Provides anti-fungal compounds, including peptides and peptidomimetics having anti-fungal activity alone, and in combination with other agents that have anti-fungal activity, and methods of using the compounds for killing or inhibit growth of yeast, mold, slimes
11/18/2004	US20040229784 Administering peptide hormones derived from atrial natriuretic factors/peptides (ANP), atriopeptin, as anticarcinogenic agents
11/18/2004	US20040229777 Crystalline phases of a potent HCV inhibitor
11/18/2004	US20040229280 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection
11/18/2004	US20040229236 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB
11/18/2004	CA2525476A1 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure
11/18/2004	CA2525191A1 Prodrugs cleavable by cd26
11/18/2004	CA2524722A1 Acylated nonadepsipeptides
11/18/2004	CA2524277A1 Arg-pro-pro-gly-phe analogs as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
11/18/2004	CA2523765A1 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
11/18/2004	CA2523410A1 Hydrolysed casein product comprising tripeptides ipp and/or vpp
11/18/2004	CA2517338A1 Hiv prodrugs cleavable by cd26
11/17/2004	EP1477493A1 Isotope coded affinity tags
11/17/2004	EP1477180A1 Inhibitors of proteasomal activity for stimulating bone and hair growth
11/17/2004	EP1476427A2 Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1476156A2 Piperidine or pyrrolidine derivatives having an aminoacyl substituted side chain as melanocortin-4 receptor agonists
11/17/2004	EP0979245B1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/17/2004	EP0956293B1 Thrombin inhibitors
11/17/2004	EP0897392B1 Peptides binding sh3 domain of cortactin and their use
11/17/2004	EP0731106B1 Dolastatin derivatives
11/17/2004	CN1176105C New anti-embolism medicine using small peptide arginine-glycine-aspartic acid (RGD) as leading compound
11/17/2004	CN1176104C Process for preparation of acetyl-guanylphenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/16/2004	US6818787 Prodrugs of GABA analogs, compositions and uses thereof
11/16/2004	US6818622 Selective MMP inhibitors having reduced side-effects
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818611 Stabilized bioactive peptides and methods of identification, synthesis and use
11/16/2004	US6818422 For preventing/treating human arteriosclerosis by inhibiting generation of foamy macrophage

1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 307